Structured Patient Education and Quality of Life of Elderly Patients With Diabetes Mellitus- a Prospective Study

NCT00444483 | Completed

• 1 other identifier: 0099-9/98 (KIMII)-955
• Study Type: interventional
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

The improvement of the quality of life (QoL) is one of the key treatment goals in patients with diabetes mellitus. Objective: Prospective study to evaluate the impact of structured diabetes education on the QoL in insulin-treated, elderly patients with type 2 diabetes mellitus. Inpatients with insulin treated type 2 diabetes or failure of oral antidiabetic therapy were successively recruited and participated in the structured inpatient diabetes treatment and teaching program (DTTP) for insulin therapy QoL was assessed before and six months after participation in the DTTP with the standardised questionnaire of Lohr analysing the subscales: social relations, physical complaints, worries about the future, diet restrictions, fear of hypoglycemia, and daily struggles.

Conditions

Impact of Structured DTTP on Quality of Life; Insulin Therapy; Metabolic Control; Psychological Aspects

Outcome Measures

Primary Outcomes (1)

• The primary outcome measure regarding patients metabolic control was the improvement of quality of life six months after DTTP.

Secondary Outcomes (1)

• A secondary objective of the study was the comparison of QoL- subscale in patients already on insulin therapy with those newly on insulin therapy.

Interventions

Structured diabetes teaching and treatment program BEHAVIORAL

Eligibility Criteria

• Age: 54 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• diabetes mellitus, insulin therapy, age \>54 years, hyperglycemia

You may not qualify if:

• dementia, severe neurological deficits, polioencephalitis, rejection of informed consent

Sponsors & Collaborators

• Heidelberg University: lead
• University of Jena: collaborator

Study Officials

• Ulrich Müller, MD

  University of Jena

  PRINCIPAL INVESTIGATOR

• Anke Braun, MD

  Bethanien Hospital Heidelberg, Germany

  STUDY CHAIR

• Ralf Schiel, MD

  Inselklinik Heringsdorf, Germany

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: March 6, 2007
• First Posted: March 7, 2007
• Last Updated: March 7, 2007

Record last verified: 2007-03